CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS) - USD ($)	12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Mar. 31, 2016
Revenues
Total revenues	$ 0	$ 0	$ 0
Operating expenses
Research and development	993,833	1,034,605	1,028,224
General and administrative	915,132	516,661	511,413
Total operating expenses	1,908,965	1,551,266	1,539,637
(Loss) from operations	(1,908,965)	(1,551,266)	(1,539,637)
Interest income	88,516	0	0
Net loss	(1,820,449)	(1,551,266)	(1,539,637)
Other comprehensive income/ (loss)
Foreign Currency Transaction Adjustment	564,914	(760,999)	135,813
Comprehensive loss	$ (1,255,535)	$ (2,312,265)	$ (1,403,824)
Loss per share
Basic and diluted	$ (0.01)	$ (0.01)	$ (0.01)
Weighted Average Number of Shares Outstanding	150,070,400	205,000,000	201,726,027